Leadership Team

Leadership Team

The leadership team at Akcea brings unmatched collective experience that is critical to guide the company’s focused effort to develop and commercialize its pipeline of therapies focused on serious and rare diseases. The team values a strong partnering ethos with physicians, patients, regulators and others in the industry, to advance critically needed therapies for the benefit of people living with these life-threatening diseases.

Paula Soteropoulos

Chief Executive Officer

Read Bio

Sarah Boyce

President

Read Bio

Jeffrey M. Goldberg

Chief Operating Officer

Read Bio

Louis St. L. O’Dea, MB B.Ch. BAO, FRCP(C)

Chief Medical Officer

Read Bio

Mike MacLean

Chief Financial Officer

Read Bio

Molly Harper

VP, and Global Franchise Head, Cardiometabolics

Read Bio

Bernard Parker

VP, Global Head & General Manager, TTR Franchise

Read Bio

Richard Jones, Ph.D.

Head of Europe

Read Bio

Michael W. Stevenson, R.Ph.,Ph.D.

VP, Medical Affairs

Read Bio

Samuel Yonren, MD

VP, Pharmacovigilance and Drug Safety

Read Bio

Joshua Patterson

VP, Legal and Chief Compliance Officer

Read Bio

Kathleen Gallagher

VP, Corporate Communications and Investor Relations

Read Bio